161 related articles for article (PubMed ID: 10647715)
1. Problems with and pitfalls of photodynamic therapy.
Peyman GA; Kazi AA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi DM
Ophthalmology; 2000 Jan; 107(1):29-35. PubMed ID: 10647715
[TBL] [Abstract][Full Text] [Related]
2. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
[TBL] [Abstract][Full Text] [Related]
3. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
Nakashizuka T; Mori K; Hayashi N; Anzail K; Kanail K; Yoneya S; Moshfeghi DM; Peyman GA
Retina; 2001; 21(5):493-8. PubMed ID: 11642379
[TBL] [Abstract][Full Text] [Related]
4. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
[TBL] [Abstract][Full Text] [Related]
5. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.
Reinke MH; Canakis C; Husain D; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
Ophthalmology; 1999 Oct; 106(10):1915-23. PubMed ID: 10519585
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM
Retina; 2001; 21(5):499-508. PubMed ID: 11642380
[TBL] [Abstract][Full Text] [Related]
7. Threshold power levels for NPe6 photodynamic therapy.
Kazi AA; Peyman GA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi D; Moshfeghi AA
Ophthalmic Surg Lasers; 2000; 31(2):136-42. PubMed ID: 10743925
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
[TBL] [Abstract][Full Text] [Related]
9. Transpupillary thermotherapy threshold parameters: funduscopic, angiographic, and histologic findings in pigmented and nonpigmented rabbits.
Peyman GA; Genaidy M; Moshfeghi DM; Ghahramani F; Yoneya S; Men G; Kuo PC; Bezerra Y; Nishiyama-Ito Y
Retina; 2003 Jun; 23(3):371-7. PubMed ID: 12824839
[TBL] [Abstract][Full Text] [Related]
10. Experimental photodynamic effects of hypocrellin A on the choriocapillaris.
Khoobehi B; Grinstead R; Passos E
Ophthalmic Surg Lasers; 2002; 33(3):207-13. PubMed ID: 12027100
[TBL] [Abstract][Full Text] [Related]
11. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
[TBL] [Abstract][Full Text] [Related]
12. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
Schlötzer-Schrehardt U; Viestenz A; Naumann GO; Laqua H; Michels S; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
[TBL] [Abstract][Full Text] [Related]
13. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
Peyman GA; Kazi AA; Moshfeghi D; Unal M; Khoobehi B; Yoneya S; Mori K; Rivera I
Ophthalmic Surg Lasers; 2000; 31(4):323-7. PubMed ID: 10928670
[TBL] [Abstract][Full Text] [Related]
14. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies.
Moshfeghi DM; Peyman GA; Moshfeghi AA; Khoobehi B; Primbs GB; Crean DH
Ophthalmic Surg Lasers; 1998 Aug; 29(8):663-8. PubMed ID: 9715492
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative.
Young LH; Howard MA; Hu LK; Kim RY; Gragoudas ES
Arch Ophthalmol; 1996 Feb; 114(2):186-92. PubMed ID: 8573023
[TBL] [Abstract][Full Text] [Related]
16. The chorioretinal damage caused by different half parameters of photodynamic therapy in rabbits.
Chuang LH; Hwang YS; Wang NK; Chen YP; Liu L; Yeung L; Chen KJ; Chen TL; Wu WC; Lai CC
J Ocul Pharmacol Ther; 2014 Oct; 30(8):642-9. PubMed ID: 24949836
[TBL] [Abstract][Full Text] [Related]
17. Choriocapillaris photodynamic therapy using indocyanine green.
Costa RA; Farah ME; Freymüller E; Morales PH; Smith R; Cardillo JA
Am J Ophthalmol; 2001 Oct; 132(4):557-65. PubMed ID: 11589879
[TBL] [Abstract][Full Text] [Related]
18. A new Chlorin formulation promotes efficient photodynamic action in choriocapillaris of rabbit's eyes.
Salomao GHA; Fernandes AU; Baptista MS; Tardivo JP; Gianssante S; Veridiano JM; Toledo OMS; Petri G; Christofolini DM; Correa JA
Bioorg Med Chem Lett; 2018 Jun; 28(10):1870-1873. PubMed ID: 29661534
[TBL] [Abstract][Full Text] [Related]
19. Histopathological changes following photodynamic therapy in human eyes.
Schmidt-Erfurth U; Laqua H; Schlötzer-Schrehard U; Viestenz A; Naumann GO
Arch Ophthalmol; 2002 Jun; 120(6):835-44. PubMed ID: 12049594
[No Abstract] [Full Text] [Related]
20. Photodynamic therapy of circumscribed choroidal hemangioma.
Porrini G; Giovannini A; Amato G; Ioni A; Pantanetti M
Ophthalmology; 2003 Apr; 110(4):674-80. PubMed ID: 12689885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]